Search

The study, led by Yale University, explore the combination with atezolizumab and radiation therapy.

Two recent reports map Spain’s ecosystem and quantify the economic potential of alternative proteins: up to €10 billion annually and 34,000 jobs in Spain by 2040 under a scenario of moderate support

GENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects (+26.5%) and 323 customers (+43.6%).

Dr Ignacio Martín-Loeches joins Viva In Vitro Diagnostics as an advisor to its Medical Advisory Board, further strengthening a committee that already includes Dr Ricard Ferrer Roca (Vall d’Hebron

Despite advances in oncology care, the persistently poor prognosis of pancreatic cancer and rising mortality rates have led to a sustained increase in productivity losses, particularly among the

Youth entrepreneurship emerges as a natural response to a changing environment, where young people seek to transform ideas into real solutions and face social challenges with creativity, initiative

Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life

A person's genetics do not change throughout their life. What does change, and does so constantly, is the scientific knowledge that allows us to interpret that information. This difference is forcing

For the treatment of aggression and social withdrawal.

The figure is significantly above the €20 million previously forecast and communicated to the market